EARLY PROGRESSION OF MANTLE CELL LYMPHOMA DEPICTS A HIGH‐RISK DISEASE WITH POOR RESPONSE TO SUBSEQUENT THERAPIES AND A DISMAL OUTCOME

Saved in:
Bibliographic Details
Published in:Hematological oncology 2019-06, Vol.37 (S2), p.242-242
Main Authors: Eskelund, C.W., Kolstad, A., Glimelius, I., Räty, R., Gjerdrum, L.R., Sonnevi, K., Josefsson, P., Nilsson‐Ehle, H., Bentzen, H., Fagerli, U., Kuittinen, O., Haaber, J., Pedersen, L.B., Larsen, M.T., Geisler, C.H., Hutchings, M., Jerkeman, M., Grønbæk, K.
Format: Article
Language:English
Subjects:
Health risks
Lymphoma
Mantle cell lymphoma
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.52_2630